179 related articles for article (PubMed ID: 24475288)
21. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance.
Mueller T; Mueller LP; Luetzkendorf J; Voigt W; Simon H; Schmoll HJ
Tumour Biol; 2006; 27(2):71-83. PubMed ID: 16557044
[TBL] [Abstract][Full Text] [Related]
22. Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity.
Giuliano CJ; Kerley-Hamilton JS; Bee T; Freemantle SJ; Manickaratnam R; Dmitrovsky E; Spinella MJ
Biochim Biophys Acta; 2005 Oct; 1731(1):48-56. PubMed ID: 16168501
[TBL] [Abstract][Full Text] [Related]
23. Stable expression of FoxA1 promotes pluripotent P19 embryonal carcinoma cells to be neural stem-like cells.
Dong D; Meng L; Yu Q; Tan G; Ding M; Tan Y
Gene Expr; 2012; 15(4):153-62. PubMed ID: 22783724
[TBL] [Abstract][Full Text] [Related]
24. Micro-RNA expression in cisplatin resistant germ cell tumor cell lines.
Port M; Glaesener S; Ruf C; Riecke A; Bokemeyer C; Meineke V; Honecker F; Abend M
Mol Cancer; 2011 May; 10():52. PubMed ID: 21575166
[TBL] [Abstract][Full Text] [Related]
25. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
[TBL] [Abstract][Full Text] [Related]
26. Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function.
Curtin JC; Dragnev KH; Sekula D; Christie AJ; Dmitrovsky E; Spinella MJ
Oncogene; 2001 May; 20(20):2559-69. PubMed ID: 11420666
[TBL] [Abstract][Full Text] [Related]
27. The pluripotency homeobox gene NANOG is expressed in human germ cell tumors.
Hart AH; Hartley L; Parker K; Ibrahim M; Looijenga LH; Pauchnik M; Chow CW; Robb L
Cancer; 2005 Nov; 104(10):2092-8. PubMed ID: 16206293
[TBL] [Abstract][Full Text] [Related]
28. NANOG priming before full reprogramming may generate germ cell tumours.
Grad I; Hibaoui Y; Jaconi M; Chicha L; Bergström-Tengzelius R; Sailani MR; Pelte MF; Dahoun S; Mitsiadis TA; Töhönen V; Bouillaguet S; Antonarakis SE; Kere J; Zucchelli M; Hovatta O; Feki A
Eur Cell Mater; 2011 Nov; 22():258-74; discussio 274. PubMed ID: 22071697
[TBL] [Abstract][Full Text] [Related]
29. Akt-signal integration is involved in the differentiation of embryonal carcinoma cells.
Chen B; Xue Z; Yang G; Shi B; Yang B; Yan Y; Wang X; Han D; Huang Y; Dong W
PLoS One; 2013; 8(6):e64877. PubMed ID: 23762260
[TBL] [Abstract][Full Text] [Related]
30. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
[TBL] [Abstract][Full Text] [Related]
31. Influence of Nodal signalling on pluripotency factor expression, tumour cell proliferation and cisplatin-sensitivity in testicular germ cell tumours.
Harpelunde Poulsen K; Nielsen JE; Grønkær Toft B; Joensen UN; Rasmussen LJ; Blomberg Jensen M; Mitchell RT; Juul A; Rajpert-De Meyts E; Jørgensen A
BMC Cancer; 2020 Apr; 20(1):349. PubMed ID: 32326899
[TBL] [Abstract][Full Text] [Related]
32. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.
Rudolph C; Melau C; Nielsen JE; Vile Jensen K; Liu D; Pena-Diaz J; Rajpert-De Meyts E; Rasmussen LJ; Jørgensen A
Cell Oncol (Dordr); 2017 Aug; 40(4):341-355. PubMed ID: 28536927
[TBL] [Abstract][Full Text] [Related]
33. Cisplatin hypersensitivity of testicular germ cell tumors is determined by high constitutive Noxa levels mediated by Oct-4.
Gutekunst M; Mueller T; Weilbacher A; Dengler MA; Bedke J; Kruck S; Oren M; Aulitzky WE; van der Kuip H
Cancer Res; 2013 Mar; 73(5):1460-9. PubMed ID: 23302226
[TBL] [Abstract][Full Text] [Related]
34. Cabazitaxel overcomes cisplatin resistance in germ cell tumour cells.
Gerwing M; Jacobsen C; Dyshlovoy S; Hauschild J; Rohlfing T; Oing C; Venz S; Oldenburg J; Oechsle K; Bokemeyer C; von Amsberg G; Honecker F
J Cancer Res Clin Oncol; 2016 Sep; 142(9):1979-94. PubMed ID: 27424191
[TBL] [Abstract][Full Text] [Related]
35. NANOG promoter methylation and expression correlation during normal and malignant human germ cell development.
Nettersheim D; Biermann K; Gillis AJ; Steger K; Looijenga LH; Schorle H
Epigenetics; 2011 Jan; 6(1):114-22. PubMed ID: 20930529
[TBL] [Abstract][Full Text] [Related]
36. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of cisplatin and etoposide cytotoxicity after all-trans retinoic-acid-induced cellular differentiation of a murine embryonal carcinoma cell line.
Guchelaar HJ; Timmer-Bosscha H; Dam-Meiring A; Uges DR; Oosterhuis JW; de Vries EG; Mulder NH
Int J Cancer; 1993 Sep; 55(3):442-7. PubMed ID: 8397165
[TBL] [Abstract][Full Text] [Related]
38. Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent.
Piulats JM; Vidal A; García-Rodríguez FJ; Muñoz C; Nadal M; Moutinho C; Martínez-Iniesta M; Mora J; Figueras A; Guinó E; Padullés L; Aytés À; Molleví DG; Puertas S; Martínez-Fernández C; Castillo W; Juliachs M; Moreno V; Muñoz P; Stefanovic M; Pujana MA; Condom E; Esteller M; Germà JR; Capella G; Farré L; Morales A; Viñals F; García-Del-Muro X; Cerón J; Villanueva A
Clin Cancer Res; 2018 Aug; 24(15):3755-3766. PubMed ID: 29618620
[No Abstract] [Full Text] [Related]
39. Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours.
Hoei-Hansen CE; Almstrup K; Nielsen JE; Brask Sonne S; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Histopathology; 2005 Jul; 47(1):48-56. PubMed ID: 15982323
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of AdOx on gene expression in P19 embryonal carcinoma cells.
Yan L; Zhao HY; Zhang Y; Shen YF
BMC Neurosci; 2012 Jan; 13():6. PubMed ID: 22221422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
